Condition: HIV · Pregnancy · HIV Antiretroviral Therapy (ART) Adherence · Sponsor: University of Pennsylvania
The goal of this study is to evaluate the effectiveness and implementation of an unconditional cash transfer intervention to improve mental bandwidth, ART adherence, and postpartum retention among pregnant women with HIV in Botswana. The main questions it seeks to answer are: 1. Do unconditional monthly cash transfers improve mental bandwidth relative to usual care among pregnant women with HIV? 2. Do unconditional monthly cash transfers improve ART adherence (PDC) during pregnancy and the postpartum period? 3. Is delivery of UCTs via mobile money feasible and acceptable in public ANC clinics in Botswana? 4. What barriers and facilitators affect implementation, and how should the model be adapted for a larger trial or a policy pilot (e.g., a pregnancy support grant)?
This description comes directly from the study's public registry record.
Aaron G Richterman, MD, MPH · 267-441-7915 · Aaron.Richterman@Pennmedicine.upenn.edu
Charlotte N Babbin, BA · 2039151038 · charlotte.babbin@pennmedicine.upenn.edu
Always discuss trial participation with your own doctor first.
| Bontleng Clinic | Gaborone, Botswana | Recruiting |
| Broadhurst 3 | Gaborone, Botswana | Recruiting |
| GWest Clinic | Gaborone, Botswana | Recruiting |
| Lesirane Clinc | Gaborone, Botswana | Recruiting |
| Mafitlhakgosi Clinic | Gaborone, Botswana | Recruiting |
| Mogoditshane Clinic | Gaborone, Botswana | Recruiting |
| Nkoyaphiri Clinic | Gaborone, Botswana | Recruiting |
| Old Naledi Clinic | Gaborone, Botswana | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07226492